Hematocrit Test Devices Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2026

Nov 2018| TMR1082A| Transparency

Report Highlights

Hematocrit Test Devices Market - Overview

This report studies the current as well as future prospects of the global hematocrit test devices market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of hematocrit test devices and new players planning to enter the market. The report comprises an elaborate executive summary, along with a market snapshot, providing overall information on various segments considered in the scope of the study. The section also provides information and data analysis of the global hematocrit test devices market in terms of product, end-user, and region.

The global hematocrit test devices market has been segmented based on product, end-user and region. In terms of product, the global market has been classified into blood analyzers, hematocrit test meter, and others. The others segment comprises reagents and accessories. Based on end-user, the global hematocrit test devices market has been segmented into hospitals & ambulatory surgical centers, clinics, diagnostic & pathology labs, and others. The hospitals & ambulatory surgical centers segment is expected to dominate the global hematocrit test devices market during the forecast period.

Bottom-up approach has been employed for determining the size of the global hematocrit test devices  market, using various market indicators obtained from secondary sources, which include analysis of launched products and mapping of sale of hematocrit test devices of top market players in specific regions. Top-down approach has been used to derive the market size of different product segments, wherein revenue of all publicly listed market players was obtained through secondary sources and analyzed for sales by narrowing down to revenue percentage for product segment through extensive analysis of annual reports, investor presentations, press releases, primary interviews, and others. Data triangulation is based on both secondary research (top-down and bottom-up approaches) and primary research. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. Market size and forecast, in terms of US$ Mn, for each segment has been provided for the period from 2016 to 2026. The report also provides compound annual growth rate (CAGR) in percentage for each segment for the forecast period from 2018 to 2026, considering 2017 as the base year.

The overview section of the report explores market dynamics such as drivers, restraints, opportunities, and key trends that have significant impact on the global hematocrit test devices market and may influence it in the near future. Market attractiveness analysis has been provided to explain the intensity of competition in the market across regions. Competitive scenario existing among the market players has been evaluated through market share analysis in the competitive landscape section of the report. These analyses are likely to help market players take strategic decisions to strengthen their positions and grow their share in the global hematocrit test devices market. The report also comprises major mergers & acquisitions, reimbursement scenario by region/global market, epidemiological overview of blood related disease diseases, and key launches & approvals.

In terms of region, the global hematocrit test devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGR for the forecast period from 2018 to 2026, considering 2017 as the base year. The report also provides market size and forecast for major countries in the above mentioned regions. A detailed qualitative analysis of factors responsible for driving and restraining the market and growth opportunities has been provided in the overview section. Competitive landscape section of the report provides analysis of market share of key players, thereby presenting a thorough analysis of the overall competitive scenario in the global drug eluting balloon market.

Major players operating in the global hematocrit test devices market are Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthineers, EKF Diagnostics Holdings plc, Sysmex Corporation, Nova Biomedical, Abbott Laboratories, HORIBA, Ltd., and Boule Diagnostics.

The global hematocrit test devices market has been segmented as follows:

Global Hematocrit Test Devices Market, by Product
Blood Analyzers
Hematocrit Test Meters
Others

Global Hematocrit Test Devices Market, by End-user
Hospitals & Ambulatory Surgical Centers
Clinics
Diagnostic & Pathology Labs
Others

Global Hematocrit Test Devices Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa

  • Table 1 : Prevalence of Anemia among Pregnant Women, by Key Countries
  • Table 2 : Prevalence of anemia among children aged 6-59 months according to Global and WHO region
  • Table 3 : Prevalence of Anemia among all women of reproductive age (15-49) years according to Global and WHO region
  • Table 4 : Comparative Analysis of Hematocrit Test Methods
  • Table 5 : Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016-2026
  • Table 6 : Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 7 : Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • Table 8 : North America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country, 2016–2026
  • Table 9 : North America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016–2026
  • Table 10 : North America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 11 : Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 12 : Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016–2026
  • Table 13 : Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 14 : Asia Pacific Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016?2026
  • Table 15 : Asia Pacific Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016?2026
  • Table 16 : Asia Pacific Hematocrit Test Devices Market value (US$ Mn) Forecast, by End-user, 2016?2026
  • Table 17 : Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016?2026
  • Table 18 : Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016?2026
  • Table 19 : Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016?2026
  • Table 20 : Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-regions, 2016–2026
  • Table 21 : Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016–2026
  • Table 22 : Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
  • Figure 1 : Global Hematocrit Test Devices Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
  • Figure 2 : Global Hematocrit Test Devices Market (US$ Mn), by Key Segment, 2017
  • Figure 3 : Global Hematocrit Test Devices Market (US$ Mn), by Key Segment and Market Share (%), 2017 Figure 4: Global Hematocrit Test Devices Market (US$ Mn), by Market Share (%), 2017
  • Figure 5 : Global Hematocrit Test Devices Market (US$ Mn), by Region (%), 2017
  • Figure 6 : Global Hematocrit Test Devices, Market Opportunity Map, by Product
  • Figure 7 : Global Hematocrit Test Devices, Market Opportunity Map, by End-user
  • Figure 8 : Key Industry Evolution/Developments
  • Figure 9 : Global Hematocrit Test Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 10 : Merger and Acquisition of major player from 2010–2018
  • Figure 11 : Recent Product Launches and Approval
  • Figure 12 : Annual number of Congenital Heart Defects births in different region
  • Figure 13 : Estimated Global Prevalence of Chronic Kidney Disease
  • Figure 14 : Estimated Global Prevalence of Leukemia
  • Figure 15 : Global Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026
  • Figure 16 : Global Hematocrit Test Devices Market Attractiveness, by Product, 2018–2026
  • Figure 17 : Global Hematocrit Test Devices Market Value Share, by Blood Analyzer Segment, 2016-2026 Figure 18: Global Hematocrit Test Devices Market Value Share, by Hematocrit Test Meters Segment, 2016-2026
  • Figure 19 : Global Hematocrit Test Devices Market Value Share, by Others, 2016-2026
  • Figure 20 : Global Hematocrit Test Market Value Share, by End-user, 2017 and 2026
  • Figure 21 : Global Hematocrit Test Market Attractiveness, End-user 2018–2026
  • Figure 22 : Global Hematocrit Test Market Value Share, by Hospitals & Ambulatory Surgical Centers Segment, 2016-2026
  • Figure 23 : Global Hematocrit Test Market Value Share, by Clinics Segment, 2016-2026
  • Figure 24 : Global Hematocrit Test Market Value Share, by Diagnostic & Pathology Labs, 2016-2026
  • Figure 25 : Global Hematocrit Test Market Value Share, by Others, 2016-2026
  • Figure 26 : Global Hematocrit Test Devices Market Value Share, by Region, 2017 and 2026
  • Figure 27 : Global Hematocrit Test Devices Market Attractiveness, Region
  • Figure 28 : North America Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 29 : North America Hematocrit Test Devices Market Value Share, by Country, 2017 and 2026
  • Figure 30 : North America Hematocrit Test Devices Market Attractiveness, by Country, 2018–2026
  • Figure 31 : North America Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026
  • Figure 32 : North America Hematocrit Test Devices Market Attractiveness, by Product, 2018–2026
  • Figure 33 : North America Hematocrit Test Devices Market Value Share, by End-user, 2017 and 2026
  • Figure 34 : North America Hematocrit Test Devices Market Attractiveness, by End-user, 2018–2026
  • Figure 35 : Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 36 : Europe Hematocrit Test Devices Market Value Share, by Country/Sub-region, 2017 and 2026 Figure 37: Europe Hematocrit Test Devices Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 38 : Europe Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026
  • Figure 39 : Europe Hematocrit Test Devices Market Attractiveness, by Product, 2018–2026
  • Figure 40 : Europe Hematocrit Test Devices Balloons Market Value Share, by End-user, 2017 and 2026 Figure 41: Europe Hematocrit Test Devices Market Attractiveness, by End-user, 2018–2026
  • Figure 42 : Asia Pacific Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016?2026
  • Figure 43 : Asia Pacific Hematocrit Test Devices Market Value Share, by Country/Sub-region, 2017 and 2026 Figure 44: Asia Pacific Hematocrit Test Devices Market Attractiveness, by Country/Sub-region, 2018?2026
  • Figure 45 : Asia Pacific Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026
  • Figure 46 : Asia Pacific Hematocrit Test Devices Market Attractiveness, by Product, 2018?2026
  • Figure 47 : Asia Pacific Hematocrit Test Devices Market Value Share, by End-user, 2017 and 2026
  • Figure 48 : Asia Pacific Hematocrit Test Devices Market Attractiveness, by End-user, 2018?2026
  • Figure 49 : Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016?2026
  • Figure 50 : Latin America Hematocrit Test Devices Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 51 : Latin America Hematocrit Test Devices Market Attractiveness, by Country/Sub-region, 2018?2026 Figure 52: Latin America Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026
  • Figure 53 : Latin America Hematocrit Test Devices Market Attractiveness, by Product, 2018?2026
  • Figure 54 : Latin America Hematocrit Test Devices Market Value Share, by End-user, 2017 and 2026
  • Figure 55 : Latin America Hematocrit Test Devices Market Attractiveness, by End-user, 2018?2026
  • Figure 56 : Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 57 : Middle East & Africa Hematocrit Test Devices Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 58 : Middle East & Africa Hematocrit Test Devices Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 59 : Middle East & Africa Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026 Figure 60: Middle East & Africa Hematocrit Test Devices Market Attractiveness, by Product, 2018–2026
  • Figure 61 : Middle East & Africa Hematocrit Test Devices Market Value Share, by End-user, 2017 and 2026 Figure 62: Middle East & Africa Hematocrit Test Devices Market Attractiveness, by End-user, 2018–2026 Figure 63: Global Hematocrit Test Devices Market, Company Share Analysis
  • Figure 64 : EKF Diagnostics Holdings plc. , Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
  • Figure 65 : EKF Diagnostics Holdings plc, Research and Development Expenses, 2013-2017
  • Figure 66 : EKF Diagnostics Holdings Plc, Breakdown of Net Sales (% Share), by Business Segment (2017)
  • Figure 67 : EKF Diagnostics Holdings plc. , Breakdown of Net Sales (% Share), by Region (2017
  • Figure 68 : Sysmex Corporation, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
  • Figure 69 : Sysmex Corporation, Research and Development Expenses, 2013-2017
  • Figure 70 : Sysmex Corporation, Breakdown of Net Sales (% Share), by Business Segment (2017)
  • Figure 71 : Sysmex Corporation, Breakdown of Net Sales (% Share), by Region (2017
  • Figure 72 : Abbott Laboratories, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
  • Figure 73 : Abbott Laboratories, Research and Development Expenses, 2013-2017
  • Figure 74 : Abbott Laboratories, Breakdown of Net Sales (% Share), by Business Segment (2017)
  • Figure 75 : Abbott Laboratories, Breakdown of Net Sales (% Share), by Region (2017)
  • Figure 76 : Nihon Kohden Corporation, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
  • Figure 77 : Nihon Kohden Corporation, Research and Development Expenses, 2013-2017
  • Figure 78 : Nihon Kohden Corporation, Breakdown of Net Sales (% Share), by Business Segment (2017)
  • Figure 79 : Nihon Kohden Corporation, Breakdown of Net Sales (% Share), by Region (2017)
  • Figure 80 : F. Hoffmann-La Roche Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
  • Figure 81 : F. Hoffmann-La Roche Ltd., Research and Development Expenses, 2013-2017
  • Figure 82 : F. Hoffmann-La Roche Ltd, Breakdown of Net Sales (% Share), by Business Segment (2017)
  • Figure 83 : F. Hoffmann-La Roche Ltd, Breakdown of Net Sales (% Share), by Region (2017)
  • Figure 84 : Danaher Corporation., Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
  • Figure 85 : Danaher Corporation, Research and Development Expenses, 2013-2017
  • Figure 86 : Danaher Corporation, Breakdown of Net Sales (% Share), by Business Segment (2017)
  • Figure 87 : Danaher Corporation, Breakdown of Net Sales (% Share), by Region (2017)
  • Figure 88 : Siemens Healthineers (Siemens AG), Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
  • Figure 89 : Siemens Healthineers (Siemens AG), Research and Development Expenses, 2013-2017
  • Figure 90 : Siemens Healthineers (Siemens AG), Breakdown of Net Sales (% Share), by Business Segment (2017)
  • Figure 91 : Siemens Healthineers (Siemens AG), Breakdown of Net Sales (% Share), by Region (2017)
  • Figure 92 : HORIBA, Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
  • Figure 93 : HORIBA, Ltd., Research and Development Expenses, 2013-2017
  • Figure 94 : HORIBA, Ltd., Breakdown of Net Sales (% Share), by Business Segment (2017)
  • Figure 95 : HORIBA, Ltd., Breakdown of Net Sales (% Share), by Region (2017)
  • Figure 96 : Boule Diagnostics, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
  • Figure 97 : Boule Diagnostics, Research and Development Expenses, 2013-2017
  • Figure 98 : Boule Diagnostics, Breakdown of Net Sales (% Share), by Business Segment (2017)
  • Figure 99 : Boule Diagnostics, Breakdown of Net Sales (% Share), by Region (2017)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report